GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Rite Aid Corp (OTCPK:RADCQ) » Definitions » EV-to-EBIT

Rite Aid (Rite Aid) EV-to-EBIT : -4.67 (As of Apr. 26, 2024)


View and export this data going back to 1970. Start your Free Trial

What is Rite Aid EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Rite Aid's Enterprise Value is $6,497 Mil. Rite Aid's EBIT for the trailing twelve months (TTM) ended in Aug. 2023 was $-1,392 Mil. Therefore, Rite Aid's EV-to-EBIT for today is -4.67.

The historical rank and industry rank for Rite Aid's EV-to-EBIT or its related term are showing as below:

RADCQ' s EV-to-EBIT Range Over the Past 10 Years
Min: -18.29   Med: 18.63   Max: 1600.2
Current: -4.67

During the past 13 years, the highest EV-to-EBIT of Rite Aid was 1600.20. The lowest was -18.29. And the median was 18.63.

RADCQ's EV-to-EBIT is ranked worse than
100% of 428 companies
in the Healthcare Providers & Services industry
Industry Median: 18.5 vs RADCQ: -4.67

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Rite Aid's Enterprise Value for the quarter that ended in Aug. 2023 was $6,532 Mil. Rite Aid's EBIT for the trailing twelve months (TTM) ended in Aug. 2023 was $-1,392 Mil. Rite Aid's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Aug. 2023 was -21.31%.


Rite Aid EV-to-EBIT Historical Data

The historical data trend for Rite Aid's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rite Aid EV-to-EBIT Chart

Rite Aid Annual Data
Trend Feb14 Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.47 46.15 90.57 -18.24 -11.05

Rite Aid Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.04 -9.31 -11.05 -8.61 -4.69

Competitive Comparison of Rite Aid's EV-to-EBIT

For the Pharmaceutical Retailers subindustry, Rite Aid's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rite Aid's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Rite Aid's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Rite Aid's EV-to-EBIT falls into.



Rite Aid EV-to-EBIT Calculation

Rite Aid's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=6496.770/-1391.678
=-4.67

Rite Aid's current Enterprise Value is $6,497 Mil.
Rite Aid's EBIT for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1,392 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rite Aid  (OTCPK:RADCQ) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Rite Aid's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Aug. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Aug. 2023 ) =EBIT / Enterprise Value (Q: Aug. 2023 )
=-1391.678/6531.990151
=-21.31 %

Rite Aid's Enterprise Value for the quarter that ended in Aug. 2023 was $6,532 Mil.
Rite Aid's EBIT for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1,392 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rite Aid EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Rite Aid's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Rite Aid (Rite Aid) Business Description

Traded in Other Exchanges
Address
1200 Intrepid Avenue, PO Box 3165, Philadelphia, PA, USA, 17105
Rite Aid Corp is a large retail drugstore chain in the United States. The company reports via two segments: retail pharmacy and pharmacy services. The retail pharmacy segment generates revenue primarily through the sale of prescription drugs, along with an assortment of merchandise that includes over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and numerous other everyday consumables. The pharmacy-services segment relates to EnvisionRx, a fully owned subsidiary that operates as a pharmacy benefit management provider offering a broad range of pharmaceutical services.
Executives
Christopher W. Dupaul officer: Chief Operating Officer 1200 INTREPID AVENUE, 2ND FLOOR, PHILADELPHIA PA 19112
Sabatino Thomas J Jr officer: Chief Legal Officer C/O JAN STERN REED BAXTER INTERNATIONAL, ONE BAXTER PARKWAY DF2 2W, DEERFIELD IL 60015
Steven Bixler officer: Chief Accounting Officer C/O RITE AID CORPORATION, 30 HUNTER LANE, CAMP HILL PA 17011
Heyward R Donigan officer: Chief Executive Officer 452 DISCOVERY ROAD, VIRGINIA BEACH VA 23451
Jocelyn Z Konrad officer: Executive VP RITE AID CORPORATION, 30 HUNTER LANE, CAMP HILL PA 17011
Ray Smithberger officer: SVP, Operations 30 HUNTER LANE, CAMP HILL PA 17011
Bari A Harlam director C/O MOHAWK GROUP HOLDINGS, INC., 37 EAST 18TH STREET, 7TH FLOOR, NEW YORK NY 10003
Paul D Gilbert officer: EVP, Secretary&General Counsel 103 POWELL COURT, SUITE 200, BRENTWOOD TN 37027
Andre Persaud officer: EVP, Retail 30 HUNTER LANE, CAMP HILL PA 17011
Dan Robson officer: President, EnvisionRXOptions 30 HUNTER LANE, CAMP HILL PA 17011
James J Peters officer: Chief Operating Officer C/O NXSTAGE MEDICAL, INC., 350 MERRIMACK STREET, LAWRENCE MA 01843
James J Comitale officer: EVP, General Counsel, Secy. 30 HUNTER LANE, CAMP HILL PA 17011
Jessica Kazmaier officer: EVP, Chief HR Officer 30 HUNTER LANE, CAMP HILL PA 17011
Justin L. Mennen officer: EVP, Chief Information Officer 30 HUNTER LANE, CAMP HILL PA 17011
Katherine B Quinn director US BANCORP, 800 NICOLLET MALL, MINNEAPOLIS MN 55402